Toevolution

Buy Now 1. The India Rapid IVD Kits Market is growing at a CAGR of ~113% (FY’2017-FY’2022), owing to a rise in awareness of Rapid IVD Tests due to the pandemic. The Rapid IVD Kits Industry has emerged as an attractive player in...

The central nervous system biomarkers market is estimated to reach at a value of US$ 4,623.5 Mn by the end of 2022 and expected to reach at a value of US$ 8,628.5 Mn by 2030 with a significant CAGR of 8.2%.

The saliva-based screening market is estimated to reach at a value of US$ 331.3 Mn by the end of 2022 and expected to reach at a value of US$ 604.0 Mn by 2030 with a significant CAGR of 7.8%.